Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
210.84B | 236.49B | 226.17B | 167.79B | 289.28B | Gross Profit |
26.03B | 29.61B | 27.26B | 20.25B | 16.22B | EBIT |
8.96B | 12.98B | 11.00B | 5.99B | 1.02B | EBITDA |
10.15B | 9.98B | 11.69B | 6.70B | -1.39B | Net Income Common Stockholders |
4.27B | 3.40B | 5.20B | 2.44B | -2.13B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
24.25B | 23.82B | 21.25B | 25.25B | 26.87B | Total Assets |
144.76B | 174.12B | 176.00B | 148.18B | 127.01B | Total Debt |
50.53B | 64.71B | 74.64B | 53.93B | 47.47B | Net Debt |
26.29B | 41.69B | 53.39B | 28.68B | 20.60B | Total Liabilities |
84.26B | 117.69B | 122.92B | 100.61B | 81.97B | Stockholders Equity |
54.52B | 50.70B | 47.75B | 42.71B | 40.01B |
Cash Flow | Free Cash Flow | |||
17.18B | 21.52B | -19.25B | -3.69B | 14.66B | Operating Cash Flow |
18.62B | 22.69B | -18.98B | -2.95B | 15.21B | Investing Cash Flow |
-2.15B | -1.42B | -326.00M | 145.00M | -790.00M | Financing Cash Flow |
-16.41B | -20.05B | 14.07B | 391.00M | -8.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥14.12B | 7.71 | 2.90% | -1.59% | -7.30% | ||
80 Outperform | ¥17.53B | 14.93 | 5.24% | 1.50% | -18.82% | ||
78 Outperform | ¥36.39B | 14.22 | 0.87% | -15.98% | -51.13% | ||
73 Outperform | ¥26.50B | 6.05 | 8.09% | -10.85% | 25.59% | ||
68 Neutral | $31.22B | 60.92 | 0.92% | 1.70% | -34.03% | -83.69% | |
68 Neutral | ¥18.13B | 4.94 | 4.68% | 21.35% | 221.64% | ||
62 Neutral | $11.80B | 10.08 | -7.46% | 2.99% | 7.37% | -8.21% |